RN7SL25P

Across TCGA pan-cancer cohorts, RN7SL25P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RN7SL25P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RN7SL25P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL25P expression acts as an unfavorable survival marker, although some lineages such as BRCA and LIHC show a favorable association.

CHOL, UCEC, and UVM are the cancer types where RN7SL25P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	54	view →
UCEC	OS	Quartile	III,IV	0.729	0.851	.002	54	view →
UVM	OS	Tertile	All	0.218	0.696	.014	36	view →
BRCA	OS	Tertile	III,IV	1.000	0.814	.021	30	view →
LUSC	DFS	Tertile	II,III,IV	0.145	0.705	<.001	30	view →
PRAD	DFS	Tertile	All	0.769	0.894	.012	18	view →
LIHC	OS	Tertile	All	0.856	0.579	.001	17	view →
THYM	OS	Tertile	II,III,IV	0.788	0.956	.007	12	view →
PAAD	DFS	Tertile	All	0.906	0.471	.020	12	view →
BLCA	OS	Tertile	IV	0.389	0.627	.012	9	view →
THCA	DFS	Tertile	IV	0.514	0.937	<.001	9	view →
KIRC	DFS	Tertile	III,IV	0.863	0.672	.024	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RN7SL25P–CHOL (OS)

Open the CHOL breakdown →